GRACELL BIOTECHNOLOGIES INC's ticker is GRCL and the CUSIP is 38406L103. A total of 33 filers reported holding GRACELL BIOTECHNOLOGIES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $683,544 | -30.3% | 297,193 | -2.4% | 0.05% | -39.2% |
Q3 2022 | $981,000 | -41.0% | 304,582 | +0.8% | 0.08% | -40.6% |
Q2 2022 | $1,662,000 | +212.4% | 302,182 | +32.4% | 0.13% | +411.5% |
Q1 2022 | $532,000 | -59.9% | 228,149 | +3.9% | 0.03% | -58.7% |
Q4 2021 | $1,327,000 | -40.0% | 219,641 | +37.7% | 0.06% | -67.9% |
Q3 2021 | $2,212,000 | +18.1% | 159,491 | +10.7% | 0.20% | +21.0% |
Q2 2021 | $1,873,000 | -8.7% | 144,055 | +8.1% | 0.16% | -17.3% |
Q1 2021 | $2,052,000 | – | 133,276 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 10,881,144 | $31,337,695 | 3.43% |
Sio Capital Management, LLC | 2,081,216 | $5,993,902 | 1.86% |
Pivotal bioVenture Partners Investment Advisor LLC | 1,375,000 | $3,960,000 | 1.58% |
TCG Crossover Management, LLC | 3,038,889 | $8,752,000 | 1.29% |
Logos Global Management LP | 2,525,000 | $7,272,000 | 0.97% |
SPHERA FUNDS MANAGEMENT LTD. | 1,531,497 | $4,410,711 | 0.80% |
Orbimed Advisors | 9,308,726 | $26,809,131 | 0.57% |
GREAT POINT PARTNERS LLC | 579,667 | $1,669,441 | 0.30% |
Temasek Holdings (Private) Ltd | 9,901,940 | $28,517,587 | 0.17% |
TANG CAPITAL MANAGEMENT LLC | 159,087 | $458,171 | 0.06% |